Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 54.40
+1.30 (2.45%)
Sep 17, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 71.29 billion as of September 17, 2026. Its market cap has increased by 191.42% in one year.
Market Cap
71.29B
Enterprise Value
69.60B
Revenue
28.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
54.40
ChartMarket Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 71.29B, an increase of 1,183.02%. That is a compound annual growth rate of 174.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 71.29B | 255.33% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 126.92B |
| Lin BioScience | 112.01B |
| CHO Pharma | 21.72B |
| Sunmax Biotechnology | 21.35B |
| Oneness Biotech | 21.19B |
| Medigen Vaccine Biologics | 19.89B |
| TaiMed Biologics | 16.28B |
| ACRO Biomedical | 15.88B |